CN Stock MarketDetailed Quotes

300765 CSPC Innovation Pharmaceutical

Watchlist
  • 28.00
  • +2.35+9.16%
Market Closed Sep 27 15:00 CST
39.33BMarket Cap62.64P/E (TTM)

CSPC Innovation Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-27.71%971.86M
-27.08%524.07M
-4.75%2.5B
0.46%1.9B
8.26%1.34B
32.84%718.72M
42.00%2.63B
80.54%1.89B
75.53%1.24B
51.49%541.03M
Operating revenue
-27.71%971.86M
-27.08%524.07M
-4.75%2.5B
0.46%1.9B
8.26%1.34B
32.84%718.72M
42.00%2.63B
80.54%1.89B
75.53%1.24B
51.49%541.03M
Other operating revenue
16.08%28.68M
----
-7.05%51.35M
----
-22.13%24.71M
----
-8.14%55.25M
----
20.31%31.73M
----
Total operating cost
-21.51%904.05M
-24.61%459.22M
-7.92%1.64B
-4.00%1.23B
36.61%1.15B
57.71%609.16M
28.31%1.79B
68.49%1.28B
64.30%843.13M
47.22%386.26M
Operating cost
-22.71%546.32M
-23.96%279.3M
-8.31%1.37B
-5.83%1.01B
0.72%706.85M
23.21%367.33M
43.25%1.49B
108.58%1.08B
109.63%701.82M
99.49%298.13M
Operating tax surcharges
-8.71%16.88M
-5.03%8.85M
40.05%28.75M
55.21%22.27M
106.28%18.49M
163.71%9.32M
29.92%20.53M
47.30%14.35M
20.70%8.96M
-22.58%3.54M
Operating expense
-35.68%73.26M
-21.44%53.04M
-15.97%205.23M
-8.40%169.92M
-6.69%113.91M
-1.97%67.51M
-8.11%244.25M
-13.22%185.5M
-20.97%122.08M
-30.17%68.87M
Administration expense
0.16%43.08M
30.91%23.71M
24.54%86.57M
16.70%54.33M
57.31%43.01M
46.73%18.11M
16.92%69.52M
60.91%46.56M
31.95%27.34M
16.98%12.34M
Financial expense
9.32%-27.35M
-356.32%-16.15M
-4.61%-90.78M
7.81%-62.54M
2.33%-30.16M
251.75%6.3M
-401.59%-86.78M
-251.52%-67.84M
-169.47%-30.88M
-28.35%-4.15M
-Interest expense (Financial expense)
-78.14%2.86M
-91.92%17.71K
62.19%355.57K
-31.08%490.54K
2,036.96%13.09M
2,297.12%219.23K
-92.26%219.23K
--711.71K
1,720.60%612.69K
--9.15K
-Interest Income (Financial expense)
15.27%-24.74M
56.61%-14.21M
-101.24%-65.9M
-110.38%-42.08M
-111.21%-29.19M
-369.57%-32.75M
-18.40%-32.75M
2.72%-20M
-20.57%-13.82M
-156.13%-6.97M
Research and development
-15.97%251.86M
-21.42%110.48M
0.52%46.54M
21.86%33.67M
2,069.64%299.71M
1,767.95%140.59M
74.71%46.3M
132.06%27.63M
91.76%13.81M
211.93%7.53M
Credit Impairment Loss
-462.24%-1.78M
-1,424.00%-5.22M
162.20%4.86M
123.89%1.83M
108.02%491.7K
87.47%-342.21K
-30.32%-7.82M
-136.25%-7.67M
-74.45%-6.13M
-24.92%-2.73M
Asset Impairment Loss
---625K
----
----
----
----
----
----
----
----
----
Other net revenue
-110.62%-818.34K
-620.97%-8.69M
132.15%33.62M
490.75%9.52M
594.61%7.7M
265.94%1.67M
-50.38%14.48M
-85.87%1.61M
-120.66%-1.56M
-114.44%-1.01M
Fair value change income
----
----
----
----
----
----
----
-41.39%1.28M
-66.56%778.14K
----
Invest income
-500.40%-3.79M
-554.56%-4.61M
-25.21%12.58M
-64.97%1.81M
-52.01%947.48K
-151.09%-704.63K
-5.05%16.82M
-33.50%5.17M
-65.15%1.97M
-49.78%1.38M
-Including: Investment income associates
-500.40%-3.79M
----
22.10%12.58M
117.17%1.81M
737.19%947.48K
----
40.92%10.3M
346.26%834.49K
-179.64%-148.7K
23.88%-743.86K
Asset deal income
----
----
----
----
----
----
--117.54K
----
----
----
Other revenue
-14.09%5.38M
-58.09%1.14M
201.67%16.18M
108.00%5.88M
243.96%6.26M
681.64%2.71M
-70.57%5.36M
-39.69%2.83M
-40.51%1.82M
-85.93%347.33K
Operating profit
-66.54%67M
-49.51%56.16M
4.18%891.35M
11.06%681.22M
-49.57%200.21M
-27.67%111.22M
75.55%855.59M
104.80%613.35M
96.74%397.04M
51.14%153.77M
Add:Non operating Income
-73.34%934.58K
-12.79%657.86K
16.04%2.89M
-4.24%6.43M
62.25%3.51M
21.53%754.32K
183.72%2.49M
614.34%6.71M
562.54%2.16M
104.58%620.67K
Less:Non operating expense
239.52%915.13K
--29.32K
-63.44%2.45M
-63.26%2.24M
-95.14%269.53K
----
-34.56%6.71M
255.14%6.09M
246.11%5.55M
540.73%3.67M
Total profit
-67.06%67.02M
-49.29%56.78M
4.75%891.79M
11.63%685.41M
-48.32%203.45M
-25.70%111.98M
78.11%851.37M
105.54%613.97M
96.31%393.65M
48.54%150.72M
Less:Income tax cost
-43.85%38.62M
-19.53%26.82M
9.39%136.47M
6.01%101.9M
11.64%68.77M
22.46%33.33M
46.28%124.76M
76.56%96.13M
64.90%61.6M
51.72%27.22M
Net profit
-78.91%28.4M
-61.90%29.96M
3.95%755.32M
12.68%583.5M
-59.44%134.68M
-36.32%78.65M
85.03%726.61M
112.00%517.85M
103.50%332.05M
47.86%123.5M
Net profit from continuing operation
-78.91%28.4M
-61.90%29.96M
3.95%755.32M
----
-59.44%134.68M
-36.32%78.65M
85.03%726.61M
----
103.50%332.05M
47.86%123.5M
Less:Minority Profit
16.58%-108.63M
3.07%-49.1M
-171.81%-239.7K
-91.25%28.06K
-64,950.89%-130.22M
-286,426.55%-50.66M
163.23%333.78K
277.06%320.6K
167.36%200.8K
94.71%-17.68K
Net profit of parent company owners
-48.27%137.03M
-38.86%79.06M
4.03%755.56M
12.74%583.48M
-20.18%264.9M
4.68%129.3M
84.70%726.28M
111.71%517.53M
103.00%331.85M
47.29%123.52M
Earning per share
Basic earning per share
-47.37%0.1
-40.44%0.0676
0.21%0.6533
-3.80%0.5066
-43.74%0.19
-43.11%0.1135
2.61%0.6519
17.62%0.5266
12.94%0.3377
29.88%0.1995
Diluted earning per share
-47.37%0.1
-40.44%0.0676
0.21%0.6533
-3.80%0.5066
-43.74%0.19
-43.11%0.1135
2.61%0.6519
17.62%0.5266
12.94%0.3377
29.88%0.1995
Other composite income
-122.58%-382.21K
-212.69%-372.43K
-34.15%1.27M
186.59%977.86K
277.73%1.69M
-134.91%-119.11K
273.95%1.92M
173.78%341.2K
222.88%448.1K
249.19%341.2K
Other composite income of parent company owners
-122.58%-382.21K
-212.69%-372.43K
-34.15%1.27M
186.59%977.86K
277.73%1.69M
-134.91%-119.11K
273.95%1.92M
173.78%341.2K
222.88%448.1K
249.19%341.2K
Total composite income
-79.46%28.02M
-62.32%29.59M
3.85%756.58M
12.79%584.48M
-58.99%136.37M
-36.59%78.53M
86.04%728.53M
112.54%518.19M
104.23%332.5M
48.67%123.84M
Total composite income of parent company owners
-48.74%136.65M
-39.09%78.69M
3.93%756.82M
12.86%584.45M
-19.77%266.59M
4.30%129.18M
85.71%728.2M
112.25%517.87M
103.73%332.3M
48.10%123.86M
Total composite income of minority owners
16.58%-108.63M
3.07%-49.1M
-171.81%-239.7K
-91.25%28.06K
-64,950.89%-130.22M
-286,426.55%-50.66M
163.23%333.78K
277.06%320.6K
167.36%200.8K
94.71%-17.68K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -27.71%971.86M-27.08%524.07M-4.75%2.5B0.46%1.9B8.26%1.34B32.84%718.72M42.00%2.63B80.54%1.89B75.53%1.24B51.49%541.03M
Operating revenue -27.71%971.86M-27.08%524.07M-4.75%2.5B0.46%1.9B8.26%1.34B32.84%718.72M42.00%2.63B80.54%1.89B75.53%1.24B51.49%541.03M
Other operating revenue 16.08%28.68M-----7.05%51.35M-----22.13%24.71M-----8.14%55.25M----20.31%31.73M----
Total operating cost -21.51%904.05M-24.61%459.22M-7.92%1.64B-4.00%1.23B36.61%1.15B57.71%609.16M28.31%1.79B68.49%1.28B64.30%843.13M47.22%386.26M
Operating cost -22.71%546.32M-23.96%279.3M-8.31%1.37B-5.83%1.01B0.72%706.85M23.21%367.33M43.25%1.49B108.58%1.08B109.63%701.82M99.49%298.13M
Operating tax surcharges -8.71%16.88M-5.03%8.85M40.05%28.75M55.21%22.27M106.28%18.49M163.71%9.32M29.92%20.53M47.30%14.35M20.70%8.96M-22.58%3.54M
Operating expense -35.68%73.26M-21.44%53.04M-15.97%205.23M-8.40%169.92M-6.69%113.91M-1.97%67.51M-8.11%244.25M-13.22%185.5M-20.97%122.08M-30.17%68.87M
Administration expense 0.16%43.08M30.91%23.71M24.54%86.57M16.70%54.33M57.31%43.01M46.73%18.11M16.92%69.52M60.91%46.56M31.95%27.34M16.98%12.34M
Financial expense 9.32%-27.35M-356.32%-16.15M-4.61%-90.78M7.81%-62.54M2.33%-30.16M251.75%6.3M-401.59%-86.78M-251.52%-67.84M-169.47%-30.88M-28.35%-4.15M
-Interest expense (Financial expense) -78.14%2.86M-91.92%17.71K62.19%355.57K-31.08%490.54K2,036.96%13.09M2,297.12%219.23K-92.26%219.23K--711.71K1,720.60%612.69K--9.15K
-Interest Income (Financial expense) 15.27%-24.74M56.61%-14.21M-101.24%-65.9M-110.38%-42.08M-111.21%-29.19M-369.57%-32.75M-18.40%-32.75M2.72%-20M-20.57%-13.82M-156.13%-6.97M
Research and development -15.97%251.86M-21.42%110.48M0.52%46.54M21.86%33.67M2,069.64%299.71M1,767.95%140.59M74.71%46.3M132.06%27.63M91.76%13.81M211.93%7.53M
Credit Impairment Loss -462.24%-1.78M-1,424.00%-5.22M162.20%4.86M123.89%1.83M108.02%491.7K87.47%-342.21K-30.32%-7.82M-136.25%-7.67M-74.45%-6.13M-24.92%-2.73M
Asset Impairment Loss ---625K------------------------------------
Other net revenue -110.62%-818.34K-620.97%-8.69M132.15%33.62M490.75%9.52M594.61%7.7M265.94%1.67M-50.38%14.48M-85.87%1.61M-120.66%-1.56M-114.44%-1.01M
Fair value change income -----------------------------41.39%1.28M-66.56%778.14K----
Invest income -500.40%-3.79M-554.56%-4.61M-25.21%12.58M-64.97%1.81M-52.01%947.48K-151.09%-704.63K-5.05%16.82M-33.50%5.17M-65.15%1.97M-49.78%1.38M
-Including: Investment income associates -500.40%-3.79M----22.10%12.58M117.17%1.81M737.19%947.48K----40.92%10.3M346.26%834.49K-179.64%-148.7K23.88%-743.86K
Asset deal income --------------------------117.54K------------
Other revenue -14.09%5.38M-58.09%1.14M201.67%16.18M108.00%5.88M243.96%6.26M681.64%2.71M-70.57%5.36M-39.69%2.83M-40.51%1.82M-85.93%347.33K
Operating profit -66.54%67M-49.51%56.16M4.18%891.35M11.06%681.22M-49.57%200.21M-27.67%111.22M75.55%855.59M104.80%613.35M96.74%397.04M51.14%153.77M
Add:Non operating Income -73.34%934.58K-12.79%657.86K16.04%2.89M-4.24%6.43M62.25%3.51M21.53%754.32K183.72%2.49M614.34%6.71M562.54%2.16M104.58%620.67K
Less:Non operating expense 239.52%915.13K--29.32K-63.44%2.45M-63.26%2.24M-95.14%269.53K-----34.56%6.71M255.14%6.09M246.11%5.55M540.73%3.67M
Total profit -67.06%67.02M-49.29%56.78M4.75%891.79M11.63%685.41M-48.32%203.45M-25.70%111.98M78.11%851.37M105.54%613.97M96.31%393.65M48.54%150.72M
Less:Income tax cost -43.85%38.62M-19.53%26.82M9.39%136.47M6.01%101.9M11.64%68.77M22.46%33.33M46.28%124.76M76.56%96.13M64.90%61.6M51.72%27.22M
Net profit -78.91%28.4M-61.90%29.96M3.95%755.32M12.68%583.5M-59.44%134.68M-36.32%78.65M85.03%726.61M112.00%517.85M103.50%332.05M47.86%123.5M
Net profit from continuing operation -78.91%28.4M-61.90%29.96M3.95%755.32M-----59.44%134.68M-36.32%78.65M85.03%726.61M----103.50%332.05M47.86%123.5M
Less:Minority Profit 16.58%-108.63M3.07%-49.1M-171.81%-239.7K-91.25%28.06K-64,950.89%-130.22M-286,426.55%-50.66M163.23%333.78K277.06%320.6K167.36%200.8K94.71%-17.68K
Net profit of parent company owners -48.27%137.03M-38.86%79.06M4.03%755.56M12.74%583.48M-20.18%264.9M4.68%129.3M84.70%726.28M111.71%517.53M103.00%331.85M47.29%123.52M
Earning per share
Basic earning per share -47.37%0.1-40.44%0.06760.21%0.6533-3.80%0.5066-43.74%0.19-43.11%0.11352.61%0.651917.62%0.526612.94%0.337729.88%0.1995
Diluted earning per share -47.37%0.1-40.44%0.06760.21%0.6533-3.80%0.5066-43.74%0.19-43.11%0.11352.61%0.651917.62%0.526612.94%0.337729.88%0.1995
Other composite income -122.58%-382.21K-212.69%-372.43K-34.15%1.27M186.59%977.86K277.73%1.69M-134.91%-119.11K273.95%1.92M173.78%341.2K222.88%448.1K249.19%341.2K
Other composite income of parent company owners -122.58%-382.21K-212.69%-372.43K-34.15%1.27M186.59%977.86K277.73%1.69M-134.91%-119.11K273.95%1.92M173.78%341.2K222.88%448.1K249.19%341.2K
Total composite income -79.46%28.02M-62.32%29.59M3.85%756.58M12.79%584.48M-58.99%136.37M-36.59%78.53M86.04%728.53M112.54%518.19M104.23%332.5M48.67%123.84M
Total composite income of parent company owners -48.74%136.65M-39.09%78.69M3.93%756.82M12.86%584.45M-19.77%266.59M4.30%129.18M85.71%728.2M112.25%517.87M103.73%332.3M48.10%123.86M
Total composite income of minority owners 16.58%-108.63M3.07%-49.1M-171.81%-239.7K-91.25%28.06K-64,950.89%-130.22M-286,426.55%-50.66M163.23%333.78K277.06%320.6K167.36%200.8K94.71%-17.68K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data